Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Integra Lifesciences Holdings Corp at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2020 / 06:00PM GMT
Release Date Price: €47 (+0.43%)
Rajbir Singh Denhoy
Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst

Thank you, everyone, again, for joining us at the Jefferies 2020 Virtual Health Care Conference. Again, I'm Raj Denhoy with the Medical Vice Research team. Up next, we have Integra LifeSciences. And from the company, we have Mike Beaulieu, who does the company's Investor Relations as well as the company's President and CEO, Pete Arduini.

So first of all, thank you guys for joining us today. We have about 25 minutes, and we're going to do Q&A. If anybody has any specific questions they want to ask, they can e-mail me, and we'll try and fit them in, but it's pretty tight.

Questions & Answers

Rajbir Singh Denhoy
Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst

So maybe, Pete, we can just start with kind of an overview of the business where it stands today. I know you've probably gotten asked this question a number of times over the last several weeks, and I don't want you to give an

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot